ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
36 announcements with these filters
Cohance Lifesciences scheduled a board meeting for August 5, 2026. The board will consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Cohance Lifesciences provided a clarification to the NSE regarding their financial results filing, confirming submission of the required XBRL and non-machine readable format documents.
Cohance Lifesciences clarified that no pending information exists regarding the recent increase in trading volume. The company remains compliant with SEBI regulations.
Cohance Lifesciences shareholders approved all five resolutions via postal ballot. The resolutions include appointment of Chairman and CEO, remuneration, and ESOP plans.
Cohance Lifesciences Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. The report notes a procedural delay in filing XBRL financial results with BSE.
Cohance Lifesciences issued a postal ballot notice for appointing Mr. Umang Vohra as Chairman and CEO. Shareholders will also vote on a new ESOP 2026 plan.